• Mukhtar Ahmad Wahid
  • George Kuruppacheril Abraham
  • Saud Abu Hamid


ABSTRACTSera from 22 patients (16 males + 6 females) with electrophoretically and immunologicallysecured diagnosis of monoclonal gammopathy were tested for various biochemical parameters. Thefinal clinical diagnosis showing gamma-globulinemias in them was in the order of multiplemyeloma (MM) 20 nos, Waldenstrom macroglobulinemia (MW) 1 no. and light chain disease(LCD) 1 no. The incidence of plasma cell neoplasm among Saudis is not very rare. The predominanttype is IgG myeloma (74%) with a kappa to lambda ratio of 2: 1. Bence Jones Proteinuria iscomparatively less common. Elevated levels of gamma glutamy l transpeptidase (GGT) in a goodnumber of patients indicate the high occurrence of hepatic involvement in such patients.


Kohn J.: A cellulose acetate supporting medium for zone electrophoresis. Clin. Chem. Acta. 1975,2, 297

Adams R.G, Smith L, Pickering P.E.C. The incidence of monoclonal proteins during seven years of screening in a

district general hospital. Immunology. 1984; 51: 451-454.

Whicher J. T: The interpretation of electrophoresis. Brit. J. Hosp. Med. 1980; 24: 348-360.

Whicher J.T.: Calvin J., J., Riches P., Warren C.: The laboratory investigation of paraproteinemia. Ann Clin. Biochem.

; 24: 119-132.

Pruzanski W: Clinical conditions associated with paraproteins. In Pruzanski W., Keystone E.C. (Eds): Paraproteins in

disease investigation of plasma cell dyscrasia. London: Churchill Livingstone, 1985; 15- 53 p. 15

Kyle R.A.: Multiple myeloma. Review of 869 cases. Mayo Clin. Proc. 50, 29, 1975.

Cohen C, Hamilton D.G.: Epidemiologic and histologic patterns of Hodgkin's disease. Comparison of black and white

populations of Johannesburg. Cancer. 46, 186, 1980.

Fine J.M., Lambin P, Leroux P.: Frequency of monoclonal gammopathy (M-components in 13400 sera from blood

donors. Vox. Sanguinis 23, 336, 1972.

Stirling G, Khalil A.M., Nada G.N. Malignant neoplasm in Saudi Arabia. Cancer. 44, 1543, 1979.

Under O.: Multiple myeloma. Dhahran health care experience. Annals of Saudi Medicine. 7,41,1987,

Berrebi A., Estrov Z: Twenty years follow up in a patient of multiple myeloma. Acta Haematological. 66, 269, 1981.

Parades J.M. Mitchell B.S., Multiple myeloma. Current concepts in diagnosis and management. Medical Clinics of

North America 64 (4), 1980.

Durie B.C.M., Salmon S.E.: clinical staging system for multiple myeloma with presenting clinical features, response to

treatment and survival. Cancer. 36, 842, 1975.

Hobbs J.R.: Growth and responses to treatment in human myelomatosis. Brit J. Haematol. 16, 607, 1969.

Perry M.C. Kyi R.A.: The clinical significance of Bence Jones proteinuria. Mayo Clin. Pro. 50, 234. 1975.

De Fronzo R.A., Cooke C.R. Wright J.R., Jumphery R.L.: Bence Jones proteinuria and renal failure in multiple

myeloma. Clin. Res. 22 468A, 1974.

Kohn J.: Cellulose acetate electrophoresis and immunoelectrophoresis. In: Smith I, ed. Chromatographic and

electrophoretic techniques. Vol. 2. London: Heinemann, 1976; p 90.

Whicher J.T., Warren C. Chambers R.E.: Immunochemical assays for immunoglobulin. Ann Clin. Biochem. 21,70,

Whicher J.T.: Immunofixation on cellulose acetate is more efficient than immunoelectrophoresis for detection of

paraproteins. Clin. Chem. 29, 402, 1983.

Bradly M., Schumann G.B., Ward P.C.J.: Examination of urine. In : Clinical diagnosis and management by laboratory

methods. In: Henry J.B.: (E.D) vol. 1. Philadelphia: Saunder W.B. 1979; p 559.

Tadashi K.: Delayed reaction of Bence Jones proteins to sulphosalicylic acid. Am. J. Clin Pathol. 86, 363, 1986.

Marinez M.M., Yuima J., Suki W.MN. Eknoyan G.: Renal complications in multiple myeloma. Physiology and some

aspects of clinical management. J. Chron. Dis. 24, 221, 1971.

Tubes R.R., Gephardt G.N. McMahan J.T., Hall P.M., Valenzuela R., Vidt D.G.: Light chain neuropathy. Am. J. Med

,263, 1981.

Pruzanski W., Gidon M.S., Roy A. Suppression of polyclonal immunoglobulin in multiple myeloma: Relationship to

the staging and other manifestations at diagnosis. Clinical Immunology and Immunopathology. 17, 280, 1980.

Zilvo J.E., Pennell P.R. (Eds): Clinical Chemistry in diagnosis and treatment. London: Lloyd-Luke Medical Books Ltd.

; p377.

Jeffery C., Eye M.K., Cohen H.J.: Evaluation of monoclonal gammopathies in the "well" elderly. Am. J. Med. 82, 39, 1987